“Finding this out, I was very proud,” said Jason Roomes, a descendant of three formerly enslaved men from Rhode Island, Cato, ...

As the United States prepares to celebrate its 250th birthday, those who portray the soldiers that fought for — and against — ...

Revolution Medicines, Inc. (NASDAQ:RVMD) is one of the 10 potential takeover targets with strong price momentum. The appeal ...

Revolution Medicines’ pan-RAS inhibitor helped patients with a highly aggressive form of pancreatic cancer live an average of six months longer than chemotherapy, hitting a goal of the phase 3 study.

The subject of buyout rumors this year, Revolution posted Phase 3 results one analyst called a “game changer” in a ...

Revolution Medicines announced a stunning survival benefit for its experimental drug in a Phase 3 pancreatic cancer study ...

The Daughters of the American Revolution welcomed the public to their headquarters Saturday to celebrate 250 years of America ...

Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, the company said.

The riots happened more than a year before the Boston Tea Party.

By Sriparna Roy April 13 (Reuters) - Revolution Medicines' experimental oral drug helped patients with pancreatic cancer live ...